Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Japanese Journal of Clinical Oncology|January 22, 2024
A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification systemYohei Chiba, Masahiro Kagabu, Mitsumasa Osakabe, et al.
International Journal of Clinical Oncology|January 15, 2025
Treatment strategies for advanced and recurrent endometrial cancer using immune checkpoint inhibitorsAmi Jo, Tadahiro Shoji, Haruka Otsuka, et al.
Cancers|July 27, 2024
Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian CancerSho Sato, Tadahiro Shoji, Ami Jo, et al.
International Journal of Clinical Oncology|January 22, 2026
Peripheral blood lymphocyte and eosinophil dynamics with chemotherapy and pembrolizumab in cervical cancerSho Sato, Masahiro Kagabu, Ami Jo, et al.
Cancers|May 13, 2026
Comparative Effectiveness of Bevacizumab and Olaparib Maintenance Therapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Real-World Study with Exploratory Evaluation of Dose ReductionShunsuke Tatsuki, Tadahiro Shoji, Ami Jo, et al.
Cancer Chemotherapy and Pharmacology|March 4, 2014
A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)Tadahiro Shoji, Eriko Takatori, Yoshitaka Kaido, et al.
International Journal of Clinical Oncology|January 17, 2026
Efficacy and safety of bevacizumab-combined single-agent chemotherapy for platinum-resistant ovarian cancer that recurred during PARP inhibitor treatmentEriko Takatori, Tadahiro Shoji, Ami Jo, et al.
International Cancer Conference Journal|June 1, 2019
Advanced squamous cell carcinomas arising from mature cystic teratoma of the ovary: a retrospective case series at the Tohoku Gynecologic Cancer UnitHideki Tokunaga, Yoh Watanabe, Michiko Kaiho, et al.
Anticancer Research|November 29, 2025
Efficacy of Platinum-based Chemotherapy for Platinum-sensitive Recurrent Ovarian Cancer During PARP Inhibitor Treatment: A Multicenter Retrospective StudyEriko Takatori, Tadahiro Shoji, Ami Jo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 24, 2010
[Results of neoadjuvant chemotherapy using tri-weekly CDDP/CPT-11 for locally advanced cervical cancer]Tadahiro Shoji, Eriko Takatori, Masatoshi Murai, et al.
Pageof 5